Breast tenderness during hormone
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Breast Cancer ~ Swine Flu ~ Lung Cancer ~ Heart attack ~ Pregnancy ~ All Health Topics
Home / Health News / 2009 / October 2009 / October 13, 2009
Breast tenderness during hormone replacement therapy may indicate cancer risk
RSS / Print / Comments

Hormone Replacement Therapy

10 tips to steer clear of breast cancer

How HRT and the Pill can lead to breast cancer

Withdrawing HRT from women cuts breast cancer risk, shows study

More on Hormone Replacement Therapy

Breast cancer

Sysmex Announces Establishment of Overseas Subsidiary in Spain to Expand Life Science Business

Breast cancer multigene test may help patients avoid chemo

Mangoes may protect against breast, colon cancer

More on Breast cancer

Health News

Watermelon effectively lowers BP
A pilot study led by food scientists at The Florida State University suggests that watermelon can be an effective natural weapon against prehypertension, a precursor to cardiovascular disease. ANI

Blame your mom for your muffin top or thunder thighs
A new study by an international team of researchers, including Cambridge and Oxford experts, has revealed that our propensity to be apple or pear-shaped is at least partly in our genes. ANI

Blame your mom for your muffin top or thunder thighs
A new study by an international team of researchers, including Cambridge and Oxford experts, has revealed that our propensity to be apple or pear-shaped is at least partly in our genes. ANI

Breast tenderness during hormone replacement therapy may indicate cancer risk

Women who develop tenderness in their br*ts after using hormone replacement therapy are at an increased risk of developing breast cancer, say researchers.


Washington, Oct 13 : Women who develop tenderness in their br*ts after using hormone replacement therapy are at an increased risk of developing breast cancer, say researchers.

However, it is still unknown why breast tenderness indicates increased cancer risk among women on estrogen plus progestin hormone replacement therapy.

"Is it because the hormone therapy is causing breast-tissue cells to multiply more rapidly, which causes breast tenderness and at the same time indicates increased cancer risk? We need to figure out what makes certain women more susceptible to developing breast tenderness during hormone therapy than other women," said Dr. Carolyn J. Crandall, a clinical professor of general internal medicine and health services research at the David Geffen School of Medicine at UCLA.

The researchers compared the daily use of oral conjugated equine estrogens (0.625 mg) plus medroxyprogesterone acetate (2.5 mg), or CEE+MPA, with the daily use of a placebo pill.

Among the women who did report breast tenderness at the beginning, the risk at one-year was about 1.26 times that of their counterparts on placebos.

Of the women who reported new-onset breast tenderness, 76.3 percent had been on the combination therapy.

Women in the combination therapy group who did not have breast tenderness at the outset but experienced new-onset tenderness at the first annual follow-up had a 48 percent higher risk of invasive breast cancer than their counterparts on combination therapy who did not have breast tenderness at the first-year follow-up.

The study is published in Archives of Internal Medicine.

ANI

Link to this page

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us